What is EchoNous?
Founded in 2016 and headquartered in Redmond, Washington, EchoNous operates at the intersection of software development and medical device engineering. The company specializes in the creation of miniaturized ultrasound systems, effectively bridging the gap between traditional, bulky diagnostic equipment and the need for rapid, bedside clinical insights. By leveraging proprietary artificial intelligence, EchoNous enhances the diagnostic capabilities of its hardware, allowing healthcare providers to perform complex imaging tasks with unprecedented ease and precision. This technological fusion is central to the company's market strategy, targeting the growing demand for efficient, high-fidelity diagnostic tools in both hospital and outpatient settings. As the industry shifts toward decentralized care, EchoNous remains at the forefront of innovation, providing clinicians with the data-driven tools necessary to improve patient outcomes through real-time, AI-assisted visualization.
How much funding has EchoNous raised?
EchoNous has raised a total of $159M across 4 funding rounds:
Private Equity
$35M
Private Equity
$60M
Series D
$57M
Other Financing Round
$7M
Private Equity (2017): $35M with participation from KKR
Private Equity (2021): $60M led by Kennedy Lewis Investment Management
Series D (2022): $57M supported by Kennedy Lewis Investment Management
Other Financing Round (2023): $7M, investors not publicly disclosed
Key Investors in EchoNous
KKR
KKR is a global investment firm investing across private markets in every asset class all over the world, KKR mission is to fortify companies and communities and help secure the futures of the institutions and individuals counting on us.
Kennedy Lewis Investment Management
Kennedy Lewis Investment Management is a multi-strategy private credit platform that specializes in non-sponsor lending and bespoke capital solutions for middle-market businesses in the U.S. and Western Europe.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for EchoNous?
With the recent influx of capital, EchoNous is well-positioned to accelerate its product development roadmap and expand its footprint in the global medical imaging market. The strategic focus will likely center on deepening the integration of machine learning algorithms into its existing ultrasound platforms, thereby increasing the diagnostic utility of its devices for a broader range of clinical applications. Furthermore, the company is expected to leverage this financial backing to scale its commercial operations, targeting key healthcare systems that prioritize efficiency and diagnostic accuracy. As EchoNous continues to refine its AI-driven diagnostic ecosystem, the firm is poised to capture additional market share, potentially setting new standards for portable medical imaging technology in an increasingly competitive enterprise-level landscape.
See full EchoNous company page
